Skip to content

Medpace Voice

Tag: Hematology

Clinical Development

Emerging Trends in Hematology – ASH 2023 Highlights

  • December 18, 2023

In December 2023, Medpace classic and malignant hematology experts attended the 65th American Hematology Society (ASH) conference in San Diego, CA. Learn more from Blythe…

Central Laboratories

[On-Demand Webinar] Liquid Biopsy in Oncology: Opportunities and Challenges

  • August 16, 2022

Join featured speakers from Medpace on September 8th, as they provide an overview of the current methodologies involved in liquid biopsies and their application for…

Company Spotlight

Blythe Thomson, MD, Rejoins Medpace Bringing New Experiences and Insights from a Sponsor’s Perspective

  • April 24, 2020

Medpace is pleased to announce that Dr. Blythe Thomson has rejoined Medpace’s Hematology and Oncology medical leadership team after spending several years holding a variety…

Clinical Development

Infectious Diseases in the Immunocompromised Host

  • February 3, 2020

An in-depth look at infectious diseases including hematologic malignancies in immunocompromised patients and the unique challenges for clinical development.

Clinical Development

Medpace’s Focus on Hematology and Oncology Aligns with Innovative Biotechs

  • February 13, 2019

Europe is a vital contributor to a new wave of technology that is changing the face of treatments and clinical development